ERIE INDEMNITY CO

ERIE
About the company

Erie Indemnity Company operates as a managing attorney-in-fact for the subscribers at the Erie Insurance Exchange in the United States. It provides issuance and renewal services; sales related services, including agent compensation and sales and advertising support services; underwriting services that include underwriting and policy processing; and other services consist of customer services and administrative support services, as well as information technology services. The company was incorporated in 1925 and is based in Erie, Pennsylvania.

Country: United StatesPrice: $274.73Market Cap: $14.4B

Investment snapshot

25%positive consensus
Scored 1d ago

Positive

4

BUY / PASS

Neutral / negative

2 / 10

NEUTRAL / FAIL

Median fair value

—

No comparable estimates

Models with upside

0 / 16

Positive margin of safety

Key risk

All 12 investors flag ERIE's valuation

Framework analysis

VerdictMeaning
BUYPositive purchase signal: the framework's buy requirements are met.
PASSThe company clears the framework's checklist or screen, but the framework does not produce a buy signal. For valuation frameworks this often means margin of safety is missing, insufficient, or unavailable; some screen-only frameworks have no intrinsic-value BUY state.
NEUTRALNeither a positive nor negative conclusion. It does not mean to hold an existing position.
FAILThe company does not clear the framework's requirements.
RankedRanked strategies do not use PASS: selected cohort is BUY, outside the cohort is FAIL, and unranked is NEUTRAL.

Current investor scores use trailing 12-month flows and the latest balance sheet where supported. Multi-year and EPS tests retain annual history; each framework shows its financial basis below. Intrinsic values use annual financials.

MetricGraham

Defensive Value

Buffett

Quality Compounder

Lynch

GARP

Piotroski

F-Score

Dreman

Contrarian Value

Munger

Quality Focus

Pabrai

Dhandho Framework

Akre

Three-Legged Stool

Marks

Risk-Aware Value

Ackman

Activist Value

Templeton

Global Bargain Hunter

Sleep

Scale Economies Shared

Asness

Systematic Factors

Neff

Low-P/E Total Return

Schloss

Asset-Value Discipline

O'Shaughnessy

Systematic Factor Composite

VerdictFAILPASSFAILPASSFAILFAILFAILFAILFAILPASSFAILBUYNEUTRALFAILFAILNEUTRAL
Score
AnalysisChecking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…Checking access…
Intrinsic Value (annual)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Margin of SafetyN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Financial Basis

TTM ended 2026-09-30 · Annual history · FY 2025

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 vs 2025-09-30 · TTM ended 2026-09-30

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Annual history · FY 2025

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Qualitative assessment · Annual history · FY 2025

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment · TTM ended 2026-09-30

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30 · Market data at 2026-11-01

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-02-23

Score computed: 2026-11-14

Annual history · FY 2025 · Qualitative assessment

Latest source filing: 2026-02-23

Score computed: 2026-11-14

TTM ended 2026-09-30 · Balance sheet at 2026-09-30 · Price history 2025-01-01–2026-11-01 · Annual history · FY 2025

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Annual history · FY 2025 · TTM ended 2026-09-30

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Annual history · FY 2025 · Balance sheet at 2026-09-30

Latest source filing: 2026-10-29

Score computed: 2026-11-14

TTM ended 2026-09-30 · Annual history · FY 2025 · Price history 2025-01-01–2026-11-01

Latest source filing: 2026-10-29

Score computed: 2026-11-14

Where It Passes

    Where It Falls Short

    • Valuation0% pass✗ 26▾

      All 12 investors flag ERIE's valuation

      Price / 3-yr avg EPS
      ✗Graham<= 15x
      Price-to-Book Ratio
      ✗Graham<= 1.5x
      P/E x P/B
      ✗Graham<= 22.5
      Basic earnings-growth PEG (dividends excluded)
      ✗Lynch< 1.0 (ideally < 0.5)
      Price / EPS
      ✗Dreman< 12x✗Templeton< 12x (fixed ceiling; proxy for the market's cheapest 40%)
      Price / (CFO / Shares)
      ✗Dreman< 8x
      Price / Book Value per Share
      ✗Dreman< 1.2x✗Templeton< 1.5x✗SchlossP/B <= 0.80x (app cutoff)
      Valuation Reasonableness
      ✗MungerP/E < 25 or Owner Earnings Yield > 5%
      P/E or FCF YieldFCF Yield=4.0%
      ✗PabraiP/E < 15 or FCF Yield > 10%
      P/B or P/E vs. Historical Average
      ✗MarksP/E < 15 or P/B < 2.0
      Discount to Intrinsic Value
      ✗Marks>= 20% below intrinsic value
      Price / FCF per Share
      ✗Ackman<= 25
      Price vs. Trailing Low125% of trailing low ($218.93)
      ✗Templeton<= 120% of trailing low (certified split-adjusted live window)
      Net income / market capitalization+4.01%; #2009/6340 (top 31.7%)
      ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
      Positive book equity / market capitalization+0.1777; #4304/6449 (top 66.7%)
      ✗AsnessTop 30% of eligible cross-section
      Price / Diluted EPS
      ✗NeffP/E <= 15x (app proxy for a P/E 40%-60% below the market)
      (EPS CAGR % + Dividend Yield %) / P/E
      ✗Neff> 0.7 (Neff's published traditional edge)
      Price / Tangible Book Value per Share
      ✗SchlossP/TBV <= 1.00x (app cutoff)
      Book Value per Share Change
      ✗SchlossLatest BVPS >= earliest BVPS over >= 3 years (app rule)
      Revenue / market capitalization+0.2870; #3378/5247 (top 64.4%)
      ✗OshaughnessyTop 10% of eligible cross-section
      (Operating cash flow - capex) / market capitalization+3.86%; #1829/4519 (top 40.5%)
      ✗OshaughnessyTop 10% of eligible cross-section
      Trailing six-month price return through the evaluation date+8.26%; #1951/6202 (top 31.5%)
      ✗OshaughnessyTop 10% of eligible cross-section
    • Debt & Leverage9% pass✓ 1✗ 12▾

      10 of 11 flag ERIE's debt & leverage — Buffett, Lynch, Dreman +7 more

      Debt/Equity & Interest Coverage
      ✗BuffettD/E < 0.5 AND Interest Coverage > 5x
      Total Debt / Equity
      ✗Lynch< 0.33
      Cash - Long-term Debt
      ✗LynchPositive preferred
      LT Debt / Total Assets Change0.00% -> 0.00%
      ✓PiotroskiDecreased YoY
      Total Debt / Shareholders' Equity
      ✗Dreman< 0.8✗Templeton< 1.0 (fixed cap; proxy for below-sector-median leverage)✗SchlossD/E < 1.00x
      Debt Levels
      ✗MungerDebt/Equity < 0.5✗AkreDebt/Equity < 0.3
      Interest Coverage & Debt/EBITDA
      ✗MarksInterest Coverage > 3x; Debt/EBITDA < 4x
      Total Debt / Shareholders Equity
      ✗Ackman<= 1.0
      Negative debt-to-equity (higher means less debt)
      ✗AsnessTop 30% of eligible cross-section
      Current Assets / Current Liabilities1.31x
      ✗SchlossCurrent ratio >= 1.50x (app cutoff)
    • Growth25% pass✓ 4✗ 8▾

      6 of 8 flag ERIE's growth — Graham, Lynch, Dreman +3 more

      EPS Growth (3-yr avg, 10-yr window)
      ✗Graham>= 33% growth
      Basic earnings-growth PEG (dividends excluded)
      ✗Lynch< 1.0 (ideally < 0.5)
      3-5 Year EPS CAGR
      ✗Lynch15-30% (Fast Grower); > 0% to pass
      EPS Growth Direction
      ✗DremanPositive over recent years
      EPS CAGR
      ✗Dreman> 5% annualized
      Positive Net Income Frequency21/21 years positive
      ✓MarksPositive net income in >= 7 of last 10 years
      3yr Median Revenue Growth15.1%
      ✓Ackman>= 5%
      Positive EPS Growth Frequency
      ✗AckmanPositive EPS growth in >= 3 of last 5 years
      5-Year EPS CAGR
      ✗Templeton> 0% (5-year EPS CAGR)
      Revenue growth vs. gross and operating margin trendrevenue up, operating margin 15.9% -> 17.6%
      ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
      5-year Revenue CAGR9.9%
      ✓SleepCAGR > 7%
      3-5 Year Diluted EPS CAGR
      ✗Neff7%-20% annualized
    • Efficiency25% pass✓ 1✗ 4▾

      3 of 4 flag ERIE's efficiency — Piotroski, Munger and Akre

      Revenue / Total Assets Change YoY1.31x -> 1.21x
      ✗PiotroskiImproved YoY
      Return on Invested Capital
      ✗Munger> 15%
      ROIC (high and growing)FY2023: ROIC=unavailable; FY2024: ROIC=unavailable; FY2025: ROIC=unavailable
      ✗AkreLatest 3 consecutive FYs: ROIC > 15% in each
      Reinvestment Rate x ROIC
      ✗AkreReinvestment Rate * ROIC > 10%
      ROIC (5-year)2/2 years above 12% (latest 20.5%)
      ✓SleepROIC > 12% in a majority of years
    • Profitability27% pass✓ 15✗ 17▾

      11 of 15 flag ERIE's profitability — Graham, Buffett, Lynch +8 more

      Positive EPS (10 years)3/21 years positive
      ✗GrahamPositive EPS every year for 10 years
      EPS Growth (3-yr avg, 10-yr window)
      ✗Graham>= 33% growth
      Net Income Positive (10+ years)21/21 years positive
      ✓BuffettPositive every year for 10+ years
      ROE (up to 5-year arithmetic mean)24.9%
      ✓Buffett> 15% arithmetic mean (app rule)
      Operating Margin (10-yr trend)17.6% (latest)
      ✗BuffettStable or rising over 10 years
      Free Cash Flow Proxy$559.3M
      ✓BuffettPositive and growing
      Earnings Variance (10-yr CoV)
      ✗BuffettCoV < 0.3
      Retained Earnings Effectiveness
      ✗Buffett$1 retained -> > $1 market value created
      Basic earnings-growth PEG (dividends excluded)
      ✗Lynch< 1.0 (ideally < 0.5)
      3-5 Year EPS CAGR
      ✗Lynch15-30% (Fast Grower); > 0% to pass
      ROE22.6%
      ✓Lynch> 15%
      Net Income / Total Assets16.67%
      ✓PiotroskiROA > 0
      ROA Change YoY20.78% -> 16.67% (delta: -4.11%)
      ✗PiotroskiCurrent ROA > Prior ROA
      (CFO / Total Assets) vs ROACFO/Assets=20.46%, ROA=16.67%
      ✓PiotroskiCFO/Assets > ROA
      Pre-Tax Income / Revenue17.8%
      ✓Dreman>= 8%
      Net Income / Shareholders' Equity22.6%
      ✓Dreman> 12%
      Margin of Safety
      ✗PabraiP/B < 1.5 or P/E < 15
      Return on Equity27.2% (3-yr avg)
      ✓AkreROE > 20% (3-year avg)
      Discount to Intrinsic Value
      ✗Marks>= 20% below intrinsic value
      Positive Net Income Frequency21/21 years positive
      ✓MarksPositive net income in >= 7 of last 10 years
      Operating Income / Revenue17.9%
      ✓Ackman>= 15%
      Net Income / Shareholders Equity22.6%
      ✓Ackman>= 15%
      5-Year EPS CAGR
      ✗Templeton> 0% (5-year EPS CAGR)
      Operating Margin Trend15.9% (2023) -> 17.6% (2025)
      ✓TempletonNon-negative operating-margin trend over 3 years
      Revenue growth vs. gross and operating margin trendrevenue up, operating margin 15.9% -> 17.6%
      ✓SleepRevenue rising; gross margin flat or falling; operating margin holding
      Net income / market capitalization+4.01%; #2009/6340 (top 31.7%)
      ✗AsnessTop 30% of eligible cross-section✗OshaughnessyTop 10% of eligible cross-section
      Gross profit / total assets
      ✗AsnessTop 30% of eligible cross-section
      Net income / positive book equity+22.57%; #690/5226 (top 13.2%)
      ✓AsnessTop 30% of eligible cross-section
      Negative 5-year standard deviation of ROA-0.0287; #1851/5884 (top 31.5%)
      ✗AsnessTop 30% of eligible cross-section
      3-5 Year Diluted EPS CAGR
      ✗Neff7%-20% annualized
      Positive Diluted-EPS Years
      ✗Schloss>= 70% positive over 5-10 observed years (app rule)
    • Verdicts29% pass✓ 4✗ 10▾

      Split decision: 10 FAIL · 3 PASS · 2 NEUTRAL · 1 BUY

      Overall verdict
      ✗GrahamFAIL (2/7)✓BuffettPASS (3/7)✗LynchFAIL (1/6)✓PiotroskiPASS (F-Score 4)✗DremanFAIL (3/10)✗MungerFAIL (1/4)✗PabraiFAIL (0/3)✗AkreFAIL (2/6)✗MarksFAIL (2/5)✓AckmanPASS (4/9)✗TempletonFAIL (3/8)✓SleepBUY (5/6)•AsnessNEUTRAL (Not ranked)✗NeffFAIL (2/6)✗SchlossFAIL (1/7)•OshaughnessyNEUTRAL (Not ranked)
    • Cash Flow50% pass✓ 6✗ 6▾

      5 of 10 pass — Lynch, Dreman, Pabrai +2 more object

      Free Cash Flow Proxy$559.3M
      ✓BuffettPositive and growing
      FCF Positive and Growing$554.0M
      ✗LynchPositive and growing
      Operating Cash Flow$686.7M
      ✓PiotroskiCFO > 0
      (CFO / Total Assets) vs ROACFO/Assets=20.46%, ROA=16.67%
      ✓PiotroskiCFO/Assets > ROA
      Price / (CFO / Shares)
      ✗Dreman< 8x
      P/E or FCF YieldFCF Yield=4.0%
      ✗PabraiP/E < 15 or FCF Yield > 10%
      FCF Positive10/10 years FCF positive
      ✓MarksPositive FCF in majority of recent years
      (OCF - CapEx) / Market Cap
      ✗Ackman>= 4%
      Price / FCF per Share
      ✗Ackman<= 25
      Positive Operating Cash Flow frequency21/21 years positive
      ✓SleepPositive OCF in >= 70% of available years
      Operating Cash Flow - Capital Expenditures$554.0M
      ✓Neff> $0 (app proxy for a strong fundamental case)
      (Operating cash flow - capex) / market capitalization+3.86%; #1829/4519 (top 40.5%)
      ✗OshaughnessyTop 10% of eligible cross-section

    Business & financials

    Financial snapshot: annual FY 2025. Current investor scores may use newer quarterly data.

    Company Profile

    Industry: Insurance
    SIC Sector: Insurance Agents & Brokers
    Size: Large Cap($14.4B)
    Revenue: $4.1B+7.2% YoY
    Net Income: $559.3M-6.8% YoY

    Financial Snapshot

    Operating Margin17.6%
    Return on Equity24.5%
    Debt / Equity--
    Current Ratio1.27
    Sector-adjusted criteria: Insurer

    Insurers file unclassified balance sheets with no inventory or current accounts, so those criteria are omitted rather than failed for missing data. Return-on-invested-capital tests are omitted too: float funds the balance sheet but never appears in invested capital, and the portfolio it is invested in would be subtracted as spare cash. Debt tests are kept — an insurer’s borrowings are real leverage on top of underwriting.

    Shareholder Return

    Fiscal 2025

    Share retirement not available for this company.

    Buybacks
    —
    Dividends
    $254.3M

    Company Financials

    Latest TTM and quarters alongside annual years

    TTM sums four consecutive quarters and uses the latest quarter-end balances. Quarter columns show three-month results; annual columns show full-year totals. Growth compares the same period a year earlier. EPS is not added for TTM; full-year ratios are blank for quarters.

    The latest annual period end is unavailable. Showing the latest fiscal cycle’s quarters; quarter and annual columns may overlap. Quarterly shows the full quarter history.

    MetricTTM · 2026-09-30

    2025-10-01 – 2026-09-30

    Sources · derived quarter values

    Derived from cumulative filings: revenue, net income, operating income, ebit, pre tax income, operating cash flow, capex, dividends paid.

    Q3 FY 2026

    2026-07-01 – 2026-09-30

    Sources · derived quarter values

    Derived from cumulative filings: operating cash flow, capex, dividends paid.

    Q2 FY 2026

    2026-04-01 – 2026-06-30

    Sources · derived quarter values

    Derived from cumulative filings: operating cash flow, capex, dividends paid.

    Q1 FY 2026

    2026-01-01 – 2026-03-31

    Sources
    FY 2025
    Sources
    • 10-K · 2026-02-23
    FY 2024
    Sources
    • 10-K · 2025-02-27
    FY 2023
    Sources
    • 10-K · 2025-02-27
    FY 2022
    Sources
    • 10-K · 2023-03-01
    FY 2021
    Sources
    • 10-K · 2022-02-24
    Market Cap$14.4Bcurrent----------------
    Revenue$4.1B↑2%$1.1B$1.1B↑3%$1.0B↑2%$4.1B↑7%$3.8B↑16%$3.3B↑15%$2.8B↑8%$2.6B
    Operating Income$736.0M↑1%$207.4M↓1%$204.1M↑2%$166.8M↑10%$717.2M↑6%$676.5M↑30%$520.3M↑38%$376.2M↑18%$318.1M
    Net Income$576.1M↓11%$182.0M$180.3M↑3%$150.5M↑9%$559.3M↓7%$600.3M↑35%$446.1M↑49%$298.6M$297.9M
    EPS (Diluted)------------------
    Gross Margin—————————
    Operating Margin17.9%↓1%19.4%↓1%18.7%16.5%↑8%17.6%↓1%17.8%↑12%15.9%↑20%13.2%↑10%12.1%
    ROE22.6%↓20%———24.5%↓19%30.2%↑13%26.8%↑30%20.6%↓7%22.2%
    Total Debt--------------$0↓100%$93.8M
    Shareholders' Equity$2.6B↑11%$2.6B↑11%$2.5B↑13%$2.4B↑14%$2.3B↑15%$2.0B↑20%$1.7B↑15%$1.4B↑8%$1.3B
    Current Ratio1.31↓22%1.31↓22%1.25↓15%1.29↓7%1.27↓11%1.43↑9%1.31↑12%1.17↓3%1.21
    Debt / Equity———————0.00↓100%0.07
    Operating Cash Flow$691.8M↓2%$213.4M↓3%$214.9M↑21%$91.9M↓22%$686.7M↑12%$611.2M↑60%$381.2M↑4%$366.2M↓9%$402.8M
    Free Cash Flow$554.0M↓4%$185.4M↑1%$173.4M↑10%$54.5M↓38%$571.0M↑17%$486.4M↑69%$288.6M↓3%$298.9M↑18%$254.0M

    Score history

    Historical Score Timeline

    Industry peers

    Industry Peers

    Similar companies in Insurance

    ERIE vs Peers — Financial Grading

    Revenue$4.1BBottom 25%
    Net Income$559.3MBottom 25%
    ROE24.5%Median
    D/E—
    Op. Margin17.6%Median
    Curr. Ratio1.27Top 25%
    CompanyMarket CapPriceRevenueNet IncomeROED/EOp. MarginCurr. RatioGrahamBuffettLynchPiotroskiDreman
    UNITEDHEALTH GROUP INCUNH$365.1B$407.46$447.6B$12.1B12.0%0.784.2%0.793/74/72/6F-Score 63/10
    PROGRESSIVE CORP/OH/PGR$136.6B$235.78$87.7B$11.3B37.3%0.23——2/72/74/6F-Score 68/10
    MARSH & MCLENNAN COMPANIES, INC.MRSH$98.8B$207.78$27.0B$4.2B27.2%1.2823.1%1.103/73/72/6F-Score 65/10
    CHINA LIFE INSURANCE CO LTDCILJF$85.1B$3.01——————5/71/73/6F-Score 55/10
    Aon plcAON$71.8B$338.31$17.2B$3.7B39.5%1.6325.3%1.112/74/73/6F-Score 63/10
    HUMANA INCHUM$54.0B$450.00$129.7B$1.2B6.7%0.702.1%2.003/72/71/6F-Score 44/10
    SUN LIFE FINANCIAL INCSLF$40.5B$72.93$30.6B$2.6B14.5%0.33——3/73/72/6F-Score 66/10
    HARTFORD INSURANCE GROUP, INC.HIG$36.8B$137.48$28.4B$3.8B20.2%0.23——3/73/74/6F-Score 78/10